Lung cancer is the major cause of death in the neoplastic diseases. In spite of the advances in the chemotherapy, the lung cancer treatments are still complex and costly, being necessary the seeking of new drugs. In this context, the ursolic acid (UA) becomes the target of studies that investigate its antitumor potential and, thus, structural modifications can enhance its biological activities. Eight UA semisynthetic derivative compounds (UAD1-8) were synthesized and evaluated their cytotoxic activity against human alveolar adenocarcinoma cells (A549). UAD1, UAD3, UAD5, UAD6 and UAD8 were able to reduce the viability of the A549 cells. Only UAD1 and UAD6 reduced the viability at 24 h, and only UAD3 didn't reduce the NF-κB expression. The compound UAD1 showed the greater apoptosis induction. Moreover, the compound UAD1 showed better results than UA in all assays. The present study shows, for the first time, the action of these compounds in the apoptotic effect, in the expression of NF-κB and in the A549 cell line. The ursolic acid derivatives showed substantial results in the apoptosis, cytotoxicity and NF-κB inhibition of A549 cells, and further studies are necessary for the development of possible new therapeutic drugs.
ti-tumor drug [6] [7] [9] [10] , however, this is the first time that is shown the action of the derivatives on apoptotic effect, on NF-κB expression and upon A549 cells. In light of the mentioned, eight UA semisynthetic derivative compounds, commonly obtained in structural modification studies, were synthesized and evaluated their cytotoxic activity against human alveolar adenocarcinoma cells (A549).
Materials and Methods

Materials
The reagents and the solvents were used directly from the manufacturers. CH 3 I (Fluka, Sigma-Aldrich, St. Louis, MO, USA); Acetone, EtOAc, t-BuOOH, n-hexane, CH 2 Cl 2 , anhydrous diethyl ether and acetic anhydride (Merck, Darmstadt, Germany); K 2 CO 3 , NaHCO 3 , NaClO 2 , Na 2 SO 4 , LiAlH 4 , BF 3 
Spectral Data
NMR spectra were recorded in CDCl 3 on a Bruker AC200 at 200 MHz for 1 H and 50 MHz for 13 C, using TMS as internal reference for both nuclei. For each peak, chemical shift values are expressed in parts per million, followed by multiplicity, relative peak integration (when appropriate), and coupling constants (J)
in Hertz. High-resolution mass spectra (HRMS) were obtained using a QSTAR XL spectrometer. The spectra in the IR were obtained in Spectrum One appara- 
MTT Assay
Cellular viability was measured using the MTT [3-(4,5-dimethylthiazolyl-2)-2,5- 
NF-κB Concentration in A549 Cells
The cells were cultured in the presence of the ursolic acid or UAD1, UAD2, UAD3, UAD4, UAD5, UAD6, UAD7 or UAD8 at 30 μM, 60 μM or 90 μM. A549 cells (1 × 10 6 cells/mL) were incubated by 24 h at 37˚C in 5% CO 2 atmosphere.
After this period, the cells were detached and stained for the analysis of the p65 expression (indirectly NF-κB), following the manufacturer's instructions (NF-KPA-B (PS529)-PE 558423, BD, Biosciences Pharmingen, San Diego, CA, USA).
The cells were acquired in the FACSVerse (BD, Biosciences Pharmingen, San Diego, CA, USA) and analyzed in the FCS Express software (De Novo software). 
Analysis of Apoptosis by Flow Cytometry
Statistical Analysis
The results represent at least three independent experiments and are presented as the mean ± SEM. All data were analyzed using two-way ANOVA followed by Bonferroni posttests (GraphPad Prism 5.00), and the differences were considered significant at p < 0.05.
Results and Discussion
Spectral Data
The eight UA semisynthetic derivative compounds were synthesized ( Figure 2 
Effect of the Ursolic Acid Derivatives on Cell Viability, NF-κB Expression and Apoptosis
Ursolic acid is a pentacyclic triterpene extracted and purified from many plant species that presents considerable pharmacological effects [5] - [11] [16] . In the present study, some of the UA derivative compounds were able to reduce the viability of A549 cells and, among these, the UAD1 showed better results. The improvement in the efficacy of UAD1 could be related to the esterification at C-28 in this compound. In HT-29, HepG2 and BGC-823 (human cancer cell lines) were already observed that UA derivatives obtained by esterification in C-3 or C-28 had increased cytotoxicity against these cells, due to the enhance in the lipophilicity and better permeability through cell membranes [17] .
In Table 1 , it is possible to observe that the compounds UAD1, UAD3, UAD5, UAD6 and UAD8 were able to reduce the viability of the A549 cells in at least one of the tested concentrations, when compared to the control (not treated A549 cells). The UAD1 was more efficient than UA to reduce the cellular viability in all concentrations tested. In the 24 h of culture (Table 2) The derivatives UAD5, UAD6 and UAD8, which have a hydroxyl in C-3, showed cytotoxicity against A549 cells at 60 µM and 90 µM. The maintenance of the hydroxyl in the C-3 and/or C-28 shows to be essential to the cytotoxicity of the derivatives since, compounds that not display this hydroxyl have reduced cytotoxic capacity [18] .
The NF-κB expression was evaluated after 24 h of culture ( Table 3) . The compounds UA, UAD1, UAD2, UAD4, UAD5, UAD6, UAD7 and UAD8 showed reduction of the NF-κB expression. The UAD1 showed the reduction in all concentrations. Interestingly, the UAD6 showed enhanced of NF-κB expression at 30 µM and the reduction in the highest concentration. This increase could be related to its inability to reduce the cell viability in this concentration probably due to its different ring conformation. Studies already showed that unprecedented conformations could change the biological activity of the synthesized compounds [19] [20] [21] [22] .
In the present study, the cytotoxicity and the NF-κB expression were evaluated in A549 cells treated with semisynthetic UA derivatives, which showed a shown that the inhibition of NF-κB expression promotes cancer cells death without effects on healthy cells, reinforcing the induction of cell death potential and the selectivity of inhibitors of this signalling pathway [25] .
The apoptosis induction was evaluated in the compounds with better results in MTT assay at 90 µM. The compound UAD1 showed the greater apoptosis induction. The UAD1 and UAD8 were significantly different from UA and A549 not treated. On the other hand, UA, UAD5 and UAD6 were different only from A549 not treated ( Figure 5 ). The ursolic acid has been demonstrated a potential apoptosis induction activity in tumor cells [26] [27] . The treatment with ursolic acid was able to restrain the invasive capacity of Gallbladder carcinoma cells and to induce apoptosis, being these effects associated with the inhibition of NF-κB [26] . In oral squamous cell carcinoma, the treatment with ursolic acid acted as a potent apoptosis inductor dependent of the caspase, being this mechanism regulated by the inhibition of the Akt/mTor/NF-κB signalling [27] .
Among the compounds were selected the UAD1, UAD5, UAD6 and UAD8 derivatives, which showed better results on cytotoxicity and NF-κB inhibition, for the apoptosis analysis. All these derivatives showed an increase in apoptosis in relation to A549 not treated cells. Moreover, the UAD1 and UAD8 showed also more apoptosis than UA treatment. Thus, can be highlighted the UAD1 derivative that showed better results than UA in all assays. In previous studies, this derivative already showed cancer cell cytotoxicity; however, not in the A549 cell line and neither the expression of NF-κB or apoptotic effect of this compound were evaluated [18] [28] . In spite of the promising results of the present study, is relevant to state that this is a preliminary study, being necessary further tests to clear the mechanism of action of these compounds. Moreover, in vivo studies need to be done to prove the same effects observed.
Conclusion
The ursolic acid derivatives showed that substantial results in the apoptosis, cytotoxicity and NF-κB inhibition of A549 cells, and further studies on the signaling pathway, also the mechanisms of action of these derivatives, are necessary for the development of possible new therapeutic drugs.
